Abstract
Context Anaplastic pancreatic carcinoma is a rare tumor with poor survival. Data on surgical and medical therapies are currently limited to case reports and case series with small numbers. Case report We describe a case of multifocal anaplastic pancreatic carcinoma treated with neoadjuvant FOLFIRINOX (oxaliplatin, irinotecan, fluorouracil and leucovorin) and total pancreatectomy with subsequent patient disease-free survival currently at 12 months. Discussion The goal for anaplastic pancreatic carcinoma treatment should continue to be complete surgical resection. Optimum chemotherapeutic options continue to be investigated.
| Original language | English |
|---|---|
| Pages (from-to) | 289-291 |
| Number of pages | 3 |
| Journal | Journal of the Pancreas |
| Volume | 14 |
| Issue number | 3 |
| State | Published - 2013 |
Keywords
- Carcinoma
- Neoadjuvant therapy
- Pancreatic neoplasms
Fingerprint
Dive into the research topics of 'Multifocal anaplastic pancreatic carcinoma requiring neoadjuvant chemotherapy and total pancreatectomy: Report of a case'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver